X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (250074) 250074
Publication (26814) 26814
Book Review (23426) 23426
Book Chapter (1435) 1435
Conference Proceeding (789) 789
Dissertation (531) 531
Newsletter (451) 451
Book / eBook (251) 251
Reference (228) 228
Magazine Article (162) 162
Government Document (137) 137
Web Resource (91) 91
Newspaper Article (49) 49
Journal / eJournal (13) 13
Data Set (11) 11
Paper (9) 9
Streaming Video (9) 9
Trade Publication Article (6) 6
Presentation (1) 1
Transcript (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (230369) 230369
humans (164932) 164932
animals (123158) 123158
mice (66310) 66310
male (61439) 61439
female (60944) 60944
oncology (53937) 53937
biochemistry & molecular biology (44355) 44355
cell biology (42148) 42148
apoptosis (41782) 41782
expression (39490) 39490
cancer (34272) 34272
phosphorylation (31880) 31880
signal transduction (31780) 31780
cell line, tumor (31222) 31222
rats (31112) 31112
proto-oncogene proteins c-akt - metabolism (27298) 27298
middle aged (27151) 27151
mutation (26096) 26096
proto-oncogene proteins - genetics (26002) 26002
proto-oncogene proteins - metabolism (25312) 25312
adult (24191) 24191
activation (23608) 23608
oncogenes (23026) 23026
cell line (22899) 22899
proteins (22713) 22713
cells, cultured (22418) 22418
gene expression (22311) 22311
aged (21021) 21021
immunohistochemistry (20978) 20978
research (20627) 20627
apoptosis - drug effects (20587) 20587
molecular sequence data (20104) 20104
proto-oncogene proteins c-bcl-2 - metabolism (17243) 17243
base sequence (16827) 16827
genetic aspects (16668) 16668
cells (16567) 16567
transfection (15385) 15385
signal transduction - drug effects (15282) 15282
tumors (15256) 15256
abridged index medicus (15248) 15248
gene (15182) 15182
article (15069) 15069
analysis (14839) 14839
tumor cells, cultured (14541) 14541
gene expression regulation, neoplastic (14467) 14467
protein (14200) 14200
cell proliferation (13849) 13849
blotting, western (13415) 13415
genetics & heredity (13289) 13289
prognosis (13287) 13287
neurosciences (13120) 13120
phosphatidylinositol 3-kinases - metabolism (13042) 13042
hematology (12996) 12996
amino acid sequence (12616) 12616
oncogene (12542) 12542
gene-expression (12220) 12220
genes (12105) 12105
pathology (11908) 11908
mice, inbred c57bl (11522) 11522
multidisciplinary sciences (11430) 11430
physiological aspects (10934) 10934
protein binding (10828) 10828
growth (10785) 10785
gene expression regulation (10667) 10667
rats, sprague-dawley (10647) 10647
time factors (10577) 10577
rna, messenger - metabolism (10557) 10557
cell proliferation - drug effects (10481) 10481
kinases (10262) 10262
in-vivo (10176) 10176
rna, messenger - genetics (10082) 10082
antineoplastic agents - pharmacology (10075) 10075
health aspects (9758) 9758
cell cycle (9731) 9731
proliferation (9720) 9720
reverse transcriptase polymerase chain reaction (9584) 9584
dna-binding proteins - genetics (9506) 9506
differentiation (9453) 9453
p53 (9387) 9387
dna-binding proteins - metabolism (9321) 9321
immunology (9294) 9294
survival (9055) 9055
aged, 80 and over (9054) 9054
down-regulation (8998) 8998
medicine, research & experimental (8967) 8967
signal transduction - physiology (8953) 8953
proto-oncogene proteins c-bcl-2 - genetics (8824) 8824
inhibition (8767) 8767
research article (8694) 8694
transcription, genetic (8691) 8691
transcription factors - metabolism (8658) 8658
polymerase chain reaction (8592) 8592
carcinoma (8587) 8587
pharmacology & pharmacy (8564) 8564
tumor suppressor protein p53 - metabolism (8502) 8502
transcription factors - genetics (8479) 8479
transcription factors (8434) 8434
disease models, animal (8422) 8422
akt (8351) 8351
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (190) 190
Online Resources - Online (91) 91
UofT at Mississauga - Stacks (13) 13
Collection Dvlpm't (Acquisitions) - Vendor file (11) 11
Collection Dvlpm't (Acquisitions) - Closed Orders (8) 8
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (8) 8
UTL at Downsview - May be requested (8) 8
Gerstein Science - Periodical Stacks (4) 4
UofT at Scarborough - Stacks (4) 4
Gerstein Science - Bindery (3) 3
Chemistry (A D Allen) - Stacks (2) 2
Gerstein Science - Circulation Desk (2) 2
Robarts - Stacks (2) 2
St. Michael's Hospital - Circulation Desk (2) 2
St. Michael's Hospital - Stacks (2) 2
Dentistry (Harry R Abbott) - Stacks (1) 1
Gerstein Science - Reference (1) 1
Media Commons - Audio Visual (1) 1
Providence Healthcare - Withdrawn (1) 1
Scarborough Hospital - Online (1) 1
UofT at Scarborough - May be requested in 6-10 wks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (242893) 242893
Chinese (4481) 4481
Japanese (1518) 1518
French (1117) 1117
Russian (700) 700
German (679) 679
Spanish (435) 435
Polish (210) 210
Portuguese (115) 115
Korean (103) 103
Italian (98) 98
Czech (81) 81
Hungarian (80) 80
Romanian (49) 49
Dutch (26) 26
Swedish (24) 24
Ukrainian (24) 24
Turkish (21) 21
Croatian (18) 18
Norwegian (18) 18
Danish (16) 16
Finnish (16) 16
Serbian (14) 14
Slovak (14) 14
Persian (11) 11
Bulgarian (9) 9
Hebrew (9) 9
Lithuanian (2) 2
Slovenian (2) 2
Arabic (1) 1
Bosnian (1) 1
Catalan (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 03/2010, Volume 464, Issue 7287, pp. 431 - 435
Activating mutations in KRAS and BRAF are found in more than 30% of all human tumours and 40% of melanoma, respectively, thus targeting this pathway could have... 
SELECTIVE INHIBITOR | POTENT | EFFICACY | PHOSPHORYLATION | MULTIDISCIPLINARY SCIENCES | IN-VIVO | C-RAF | HETERODIMERIZATION | B-RAF | PROTEIN-KINASE KINASE | CANCER | Neoplasms - metabolism | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Diphenylamine - pharmacology | raf Kinases - antagonists & inhibitors | Humans | Protein Multimerization | ras Proteins - metabolism | Protein Transport - drug effects | Extracellular Signal-Regulated MAP Kinases - metabolism | raf Kinases - metabolism | Diphenylamine - analogs & derivatives | Mitogen-Activated Protein Kinase Kinases - metabolism | Adenosine Triphosphate - metabolism | Indoles - pharmacology | Benzamides - pharmacology | Cell Membrane - metabolism | raf Kinases - genetics | Cell Membrane - drug effects | Proto-Oncogene Proteins B-raf - metabolism | Proto-Oncogene Proteins B-raf - chemistry | Pyrazoles - pharmacology | Protein Structure, Tertiary | Proto-Oncogene Proteins - metabolism | Cell Line | Indenes - pharmacology | raf Kinases - chemistry | Proto-Oncogene Proteins c-raf - genetics | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | Neoplasms - enzymology | Proto-Oncogene Proteins - genetics | Enzyme Activation - drug effects | Sulfonamides - pharmacology | Proto-Oncogene Proteins c-raf - metabolism | Neoplasms - drug therapy | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Xenograft Model Antitumor Assays | Animals | MAP Kinase Signaling System - drug effects | Protein Kinase Inhibitors - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Proto-Oncogene Proteins c-raf - deficiency | Cell Proliferation - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Neoplasms - pathology | Ras genes | Growth | Physiological aspects | Cellular signal transduction | Genetic aspects | Research | Mitogen-activated protein kinases | Competition | Clinical trials | Enzymes | Kinases | Index Medicus | Proteins | Cellular | Inhibitors | Pathways | Tumours | Signalling | Dimerization
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 05/2012, Volume 18, Issue 9, pp. 2502 - 2514
Purpose: The clinical use of BRAF inhibitors is being hampered by the acquisition of drug resistance. This study shows the potential therapeutic use of the... 
BREAST-CANCER | MULTIPLE-MYELOMA | APOPTOSIS | PHASE-II TRIAL | TANESPIMYCIN 17-AAG | TRASTUZUMAB | ONCOLOGY | BIM | ACQUIRED-RESISTANCE | MELANOMA-CELLS | POTENTIAL MECHANISM | Prospective Studies | Apoptosis - drug effects | Humans | Extracellular Signal-Regulated MAP Kinases - antagonists & inhibitors | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Immunoenzyme Techniques | Forkhead Transcription Factors - metabolism | Colony-Forming Units Assay | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Phthalic Acids - pharmacology | Proto-Oncogene Proteins c-akt - metabolism | Real-Time Polymerase Chain Reaction | Proto-Oncogene Proteins B-raf - metabolism | Membrane Proteins - genetics | Melanoma - pathology | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Apoptosis Regulatory Proteins - metabolism | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Indoles - adverse effects | Membrane Proteins - antagonists & inhibitors | Signal Transduction - drug effects | HSP90 Heat-Shock Proteins - antagonists & inhibitors | Cell Line, Tumor | HSP90 Heat-Shock Proteins - metabolism | Mice | Mice, Inbred BALB C | Forkhead Box Protein O3 | Azabicyclo Compounds - pharmacology | Phosphatidylinositol 3-Kinases - metabolism | Extracellular Signal-Regulated MAP Kinases - metabolism | Extracellular Signal-Regulated MAP Kinases - genetics | Proto-Oncogene Proteins c-akt - genetics | Proto-Oncogene Proteins c-bcl-2 - metabolism | Flow Cytometry | Bcl-2-Like Protein 11 | Apoptosis Regulatory Proteins - genetics | Membrane Proteins - metabolism | Forkhead Transcription Factors - antagonists & inhibitors | Melanoma - metabolism | Proto-Oncogene Proteins - metabolism | Proto-Oncogene Proteins - antagonists & inhibitors | RNA, Messenger - genetics | Proto-Oncogene Proteins - genetics | Forkhead Transcription Factors - genetics | Phosphatidylinositol 3-Kinases - genetics | Animals | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Myeloid Cell Leukemia Sequence 1 Protein | Apoptosis Regulatory Proteins - antagonists & inhibitors | Fluorescent Antibody Technique | Sulfonamides - adverse effects | Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Proto-Oncogene Proteins c-bcl-2 - genetics | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Drug Resistance, Neoplasm - drug effects | Index Medicus
Journal Article
1988, Research in., ISBN 0861961617, 271
Book
Journal Article
Nature, ISSN 0028-0836, 12/2010, Volume 468, Issue 7326, pp. 968 - 972
Oncogenic mutations in the serine/threonine kinase B-RAF (also known as BRAF) are found in 50-70% of malignant melanomas. Pre-clinical studies have... 
TRANSFORMATION | CELLS | TUMOR PROGRESSION | GENE | SIGNALING PATHWAY | MULTIDISCIPLINARY SCIENCES | BRAF | B-RAF | KAPPA-B | MUTATIONS | CANCER | Allosteric Regulation | Humans | Gene Expression Regulation, Neoplastic | Melanoma - enzymology | Gene Expression Profiling | MAP Kinase Signaling System | Mitogen-Activated Protein Kinase Kinases - metabolism | Melanoma - genetics | Indoles - pharmacology | Proto-Oncogene Proteins B-raf - metabolism | Proto-Oncogene Proteins B-raf - chemistry | Melanoma - metabolism | Proto-Oncogene Proteins - metabolism | Gene Library | Proto-Oncogene Proteins c-raf - genetics | MAP Kinase Kinase Kinases - genetics | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | Proto-Oncogene Proteins - genetics | Clinical Trials as Topic | MAP Kinase Kinase Kinases - metabolism | Enzyme Activation - drug effects | Open Reading Frames - genetics | Sulfonamides - pharmacology | Proto-Oncogene Proteins c-raf - metabolism | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Drug Resistance, Neoplasm - genetics | Sulfonamides - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Cell Line, Tumor | Indoles - therapeutic use | Protein Kinase Inhibitors - pharmacology | Drug Resistance, Neoplasm - drug effects | Mitogen-Activated Protein Kinases - metabolism | Protein research | Research | Properties | Protein kinases | Cancer cells | Cell lines | Biochemistry | Mutation | Kinases | Genes | Cancer | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 04/2016, Volume 122, Issue 7, pp. 1097 - 1107
Journal Article
Molecular Cell, ISSN 1097-2765, 06/2015, Volume 58, Issue 6, pp. 1028 - 1039
The bromodomain and extraterminal (BET) protein BRD4 is a validated drug target in leukemia, yet its regulatory function in this disease is not well... 
SELECTIVE-INHIBITION | RECRUITMENT | C/EBP-ALPHA | CREB-BINDING PROTEIN | CHROMATIN | ACETYLATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | IN-VIVO | C-MYC | P-TEFB | BRD4 | CELL BIOLOGY | Transcriptional Regulator ERG | NIH 3T3 Cells | Oncogene Proteins - genetics | Humans | Leukemia, Myeloid - genetics | Proto-Oncogene Proteins c-myb - genetics | Gene Expression Profiling | Leukemia, Myeloid - pathology | RNA Interference | Proto-Oncogene Protein c-fli-1 - metabolism | Protein Binding - drug effects | Trans-Activators - genetics | Nuclear Proteins - genetics | Proto-Oncogene Proteins - metabolism | Acute Disease | Proto-Oncogene Protein c-fli-1 - genetics | CCAAT-Enhancer-Binding Protein-beta - genetics | Oncogene Proteins - metabolism | Nuclear Proteins - metabolism | Proto-Oncogene Proteins - genetics | Transcription Factors - antagonists & inhibitors | Transcription Factors - genetics | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | CCAAT-Enhancer-Binding Protein-beta - metabolism | Proto-Oncogene Proteins c-myb - metabolism | Azepines - pharmacology | Transcription Factors - metabolism | Triazoles - pharmacology | Acetylation - drug effects | Animals | Hematopoietic System - metabolism | Leukemia, Myeloid - metabolism | Nuclear Proteins - antagonists & inhibitors | Cell Line, Tumor | Trans-Activators - metabolism | Mice | Histones - metabolism | DNA binding proteins | Medicine, Experimental | Medical research | Chromatin | Lysine | Index Medicus
Journal Article
Oncogene, ISSN 0950-9232, 1987
Journal
Oncogene, ISSN 0950-9232, 1987
Journal
Molecular Cell, ISSN 1097-2765, 11/2016, Volume 64, Issue 3, pp. 493 - 506
amplification in human cancers predicts poor prognosis and resistance to therapy. However, pharmacological strategies that directly target N-Myc, the protein... 
BI6727 | targeted therapy | ubiquitination | Myc | PLK1 | neuroblastoma | Fbw7 | small cell lung carcinoma | ABT199 | TARGETED THERAPY | INHIBITOR VOLASERTIB | BIOCHEMISTRY & MOLECULAR BIOLOGY | N-MYC | C-MYC | F-BOX PROTEINS | AMPLIFIED NEUROBLASTOMA | AURORA KINASE | FBW7 UBIQUITIN LIGASE | CANCER-THERAPY | HUMAN NEUROBLASTOMA | CELL BIOLOGY | RNA, Small Interfering - genetics | Humans | Neuroblastoma - mortality | N-Myc Proto-Oncogene Protein - antagonists & inhibitors | Transcription, Genetic | Neurons - metabolism | Brain Neoplasms - mortality | Protein-Serine-Threonine Kinases - metabolism | Signal Transduction | Cell Cycle Proteins - metabolism | Ubiquitin-Protein Ligases - metabolism | Brain Neoplasms - genetics | Brain Neoplasms - drug therapy | Sulfonamides - pharmacology | Drug Synergism | Bridged Bicyclo Compounds, Heterocyclic - pharmacology | Feedback, Physiological | Mice, Nude | Survival Analysis | Cell Line, Tumor | Ubiquitin-Protein Ligases - genetics | F-Box Proteins - genetics | RNA, Small Interfering - metabolism | F-Box-WD Repeat-Containing Protein 7 | Neurons - pathology | Brain Neoplasms - pathology | Gene Expression Regulation, Neoplastic | N-Myc Proto-Oncogene Protein - genetics | Cell Cycle Proteins - antagonists & inhibitors | Proto-Oncogene Proteins c-bcl-2 - metabolism | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Cell Cycle Proteins - genetics | Antineoplastic Agents - pharmacology | Neurons - drug effects | Neuroblastoma - pathology | Proto-Oncogene Proteins - metabolism | Proto-Oncogene Proteins - antagonists & inhibitors | Pteridines - pharmacology | F-Box Proteins - metabolism | Neuroblastoma - genetics | Protein-Serine-Threonine Kinases - genetics | Proto-Oncogene Proteins - genetics | Xenograft Model Antitumor Assays | Animals | Tumor Burden - drug effects | N-Myc Proto-Oncogene Protein - metabolism | Neuroblastoma - drug therapy | Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors | Proto-Oncogene Proteins c-bcl-2 - genetics | Ubiquitin | Polo | Ligases | Lung cancer | Therapeutics | Homeopathy | Materia medica and therapeutics | Cancer | Index Medicus
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 6, pp. 9251 - 9266
Activating mutations in the KRAS and BRAF genes, leading to hyperactivation of the RAS/RAF/MAPK oncogenic signaling cascade, are common in patients with... 
Signaling pathways | Xenograft models | RAS | RAF | Colorectal cancer | WILD-TYPE | colorectal cancer | ACTIVATED PROTEIN-KINASE | TUMOR PROGRESSION | xenograft models | ACQUIRED-RESISTANCE | ANTI-EGFR THERAPY | LY2228820 DIMESYLATE | CELL BIOLOGY | SELECTIVE INHIBITOR | signaling pathways | RAF INHIBITORS | NEGATIVE FEEDBACK | MAPK PATHWAY | Apoptosis - drug effects | Proto-Oncogene Proteins p21(ras) - genetics | Colorectal Neoplasms - genetics | Humans | Extracellular Signal-Regulated MAP Kinases - metabolism | Rats, Nude | Dose-Response Relationship, Drug | Transfection | RNA Interference | Time Factors | Colorectal Neoplasms - drug therapy | Female | Antineoplastic Agents - pharmacology | Proto-Oncogene Proteins c-akt - metabolism | Proto-Oncogene Proteins B-raf - metabolism | Proto-Oncogene Proteins A-raf - antagonists & inhibitors | Colorectal Neoplasms - enzymology | Genetic Predisposition to Disease | Proto-Oncogene Proteins c-raf - genetics | HCT116 Cells | Proto-Oncogene Proteins A-raf - genetics | Pyrimidines - pharmacology | Proto-Oncogene Proteins c-raf - metabolism | Proto-Oncogene Proteins A-raf - metabolism | HT29 Cells | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Phenotype | Animals | Tumor Burden - drug effects | Proto-Oncogene Proteins B-raf - genetics | Cell Proliferation - drug effects | Phenylurea Compounds - pharmacology | Protein Kinase Inhibitors - pharmacology | Proto-Oncogene Proteins c-raf - antagonists & inhibitors | Mutation | Colorectal Neoplasms - pathology | G1 Phase Cell Cycle Checkpoints - drug effects | Index Medicus
Journal Article
Cancer Research, ISSN 0008-5472, 04/2011, Volume 71, Issue 7, pp. 2750 - 2760
This study addresses the role of PTEN loss in intrinsic resistance to the BRAF inhibitor PLX4720. Immunohistochemical staining of a tissue array covering all... 
METASTATIC MELANOMA | APOPTOSIS | PROTEIN | ONCOLOGY | PHOSPHORYLATION | CUTANEOUS MELANOMA | RAF KINASE | CANCER | MEDIATES RESISTANCE | LINES | ERK | RNA, Small Interfering - genetics | Up-Regulation | Humans | Drug Resistance, Neoplasm | Phosphatidylinositol 3-Kinases - metabolism | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Proto-Oncogene Proteins - biosynthesis | Bcl-2-Like Protein 11 | Melanoma - genetics | Apoptosis Regulatory Proteins - genetics | Indoles - pharmacology | Proto-Oncogene Proteins c-akt - metabolism | Proto-Oncogene Proteins B-raf - metabolism | Apoptosis Regulatory Proteins - biosynthesis | Melanoma - metabolism | Proto-Oncogene Proteins - antagonists & inhibitors | PTEN Phosphohydrolase - deficiency | Membrane Proteins - genetics | PTEN Phosphohydrolase - biosynthesis | Proto-Oncogene Proteins - genetics | Melanoma - pathology | Sulfonamides - pharmacology | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Membrane Proteins - biosynthesis | Membrane Proteins - antagonists & inhibitors | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Apoptosis Regulatory Proteins - antagonists & inhibitors | Cell Line, Tumor | Protein Kinase Inhibitors - pharmacology | Apoptosis - physiology | Mutation | RNA, Small Interfering - administration & dosage | Index Medicus | PTEN | melanoma | BRAF | PLX4032 | therapy | resistance
Journal Article
Nucleic Acids Research, ISSN 0305-1048, 03/2011, Volume 39, Issue 5, pp. 1880 - 1893
The Epstein-Barr virus (EBV) is an oncogenic human Herpes virus found in similar to 15% of diffuse large B-cell lymphoma (DLBCL). EBV encodes miRNAs and... 
TRANSCRIPTION FACTORS | MIR-155 | ACTIVATION | MESSENGER-RNA | GENE | INDUCED CYTIDINE DEAMINASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | ACUTE LYMPHOBLASTIC-LEUKEMIA | EXPRESSION PROFILES | BETA-CATENIN | C-MYB PROTOONCOGENE | Herpesvirus 4, Human - genetics | Humans | Gene Expression Regulation, Neoplastic | Proto-Oncogene Proteins c-myb - genetics | MicroRNAs - metabolism | Gene Expression Profiling | Wnt Proteins - metabolism | Epstein-Barr Virus Infections - genetics | RNA, Small Untranslated - genetics | Nuclear Proteins - genetics | Binding Sites | Cell Line | Epstein-Barr Virus Infections - virology | Gene Library | Molecular Sequence Annotation | Ubiquitin-Protein Ligases - metabolism | Nuclear Proteins - metabolism | Proto-Oncogene Proteins - genetics | DNA-Binding Proteins - genetics | Reverse Transcriptase Polymerase Chain Reaction | beta Catenin - metabolism | Lymphoma, Large B-Cell, Diffuse - virology | Proto-Oncogene Proteins c-myb - metabolism | MicroRNAs - genetics | Herpesvirus 4, Human - metabolism | Ubiquitin-Protein Ligases - genetics | Lymphoma, Large B-Cell, Diffuse - genetics | Index Medicus | Lymphoma, Large B-Cell, Diffuse | beta Catenin | Wnt Proteins | Proto-Oncogene Proteins c-myb | Herpesvirus 4, Human | Nuclear Proteins | Ubiquitin-Protein Ligases | Life Sciences | MicroRNAs | Proto-Oncogene Proteins | RNA, Small Untranslated | Epstein-Barr Virus Infections | DNA-Binding Proteins | Cancer | RNA
Journal Article